Bank of New York Mellon Corp - DECIPHERA PHARMACEUTICALS IN ownership

DECIPHERA PHARMACEUTICALS IN's ticker is DCPH and the CUSIP is 24344T101. A total of 163 filers reported holding DECIPHERA PHARMACEUTICALS IN in Q3 2021. The put-call ratio across all filers is 0.21 and the average weighting 0.2%.

Quarter-by-quarter ownership
Bank of New York Mellon Corp ownership history of DECIPHERA PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2023$2,603,173
-9.8%
204,652
-0.1%
0.00%0.0%
Q2 2023$2,884,641
-1.6%
204,875
+7.9%
0.00%0.0%
Q1 2023$2,932,781
+2.0%
189,824
+8.2%
0.00%0.0%
Q4 2022$2,876,560
-8.5%
175,507
+3.3%
0.00%0.0%
Q3 2022$3,143,000
+57.5%
169,928
+12.0%
0.00%
Q2 2022$1,995,000
+50.0%
151,762
+5.8%
0.00%
Q1 2022$1,330,000
-0.7%
143,498
+4.7%
0.00%
Q4 2021$1,339,000
-76.4%
137,038
-17.8%
0.00%
-100.0%
Q3 2021$5,667,000
-2.2%
166,788
+5.4%
0.00%0.0%
Q2 2021$5,795,000
-28.8%
158,291
-12.8%
0.00%
-50.0%
Q1 2021$8,139,000
-24.0%
181,514
-3.3%
0.00%0.0%
Q4 2020$10,709,000
+20.4%
187,640
+8.3%
0.00%0.0%
Q3 2020$8,892,000
-12.2%
173,326
+2.3%
0.00%
-33.3%
Q2 2020$10,123,000
+103.2%
169,490
+40.1%
0.00%
+50.0%
Q1 2020$4,981,000
-31.3%
120,997
+3.9%
0.00%0.0%
Q4 2019$7,250,000
+120.9%
116,494
+20.5%
0.00%
+100.0%
Q3 2019$3,282,000
+148.8%
96,692
+65.4%
0.00%
Q2 2019$1,319,000
+20.6%
58,468
+24.1%
0.00%
Q1 2019$1,094,000
+11.5%
47,126
+0.9%
0.00%
Q4 2018$981,000
-61.8%
46,704
-29.7%
0.00%
-100.0%
Q3 2018$2,571,000
+15.8%
66,408
+17.7%
0.00%0.0%
Q2 2018$2,221,000
+370.6%
56,442
+139.5%
0.00%
Q1 2018$472,000
+21.6%
23,564
+37.9%
0.00%
Q4 2017$388,00017,0850.00%
Other shareholders
DECIPHERA PHARMACEUTICALS IN shareholders Q3 2021
NameSharesValueWeighting ↓
New Leaf Venture Partners, L.L.C. 1,209,571$15,385,74319.76%
Redmile Group, LLC 4,475,384$56,926,8842.71%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 6,897,606$87,737,5481.93%
Parkman Healthcare Partners LLC 597,403$7,598,9661.39%
Ghost Tree Capital, LLC 325,000$4,134,0001.36%
BRAIDWELL LP 3,336,221$42,436,7311.34%
AlphaCentric Advisors LLC 132,000$1,679,0400.95%
ARMISTICE CAPITAL, LLC 4,612,000$58,664,6400.90%
Sunesis Advisors, LLC 96,299$1,224,9230.87%
EcoR1 Capital, LLC 993,000$12,630,9600.43%
View complete list of DECIPHERA PHARMACEUTICALS IN shareholders